Status:
COMPLETED
Enhancing Social Competence in Adults With Autism
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
SENSE Theatre®, combines several well-documented, effective behavioral strategies, such as the inclusion of trained peer models, theatre play techniques involving predictable (i.e., scripted) and flex...
Detailed Description
Autism spectrum disorder (ASD) is characterized by primary impairment in social competence. Effects of current psychosocial interventions often fail to maintain or generalize and few employ rigorous e...
Eligibility Criteria
Inclusion
- ASD
- diagnosed with ASD based on DSM-V criteria (APA, 2013), by a psychologist, pediatrician or psychiatrist with expertise in ASD will be enrolled. ASD diagnosis will be corroborated by the Autism Diagnostic Observation Schedule (ADOS-2) (Lord, 2012).
- Only adults not currently supported by educational opportunities will be enrolled.
- Participants must have a full-scale IQ \> or = 70 (WASI; (Wechsler, 2011))
- ASD
Exclusion
- Adults with intellectual impairment (WASI; (Wechsler, 2011) score \< 70.
- Participants with current, frequent and uncontrolled aggression toward other persons or property in the past 6 months will be excluded based on phone screening and questions from the Adult Behavior Checklist (Achenbach, 2001) (e.g., "Physically attacks people").
- Participants with evidence of suicidality based on care-provider report, self-report, or clinical interview (i.e., endorsement of suicidal ideation in the past month and/or suicidal behavior in the past three months on the Columbia Suicide Severity Rating Scale (Posner, 2011),
- Previous SENSE Theatre® participants will be excluded.
- Care-giver Inclusion Criteria:
- must be at least 18 years of age
- must be a parent, close relative, or spouse of the adult participant with ASD.
- must be able to provide current and historical observations of the functioning of the participant with ASD.
- must live in close proximity to and have frequent contact with the participant with ASD.
- Care-giver
Key Trial Info
Start Date :
October 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2025
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04349644
Start Date
October 21 2020
End Date
March 30 2025
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212